ecancermedicalscience

Special Issue

Cancer prevention and control: Kaposi’s sarcoma

25 Jul 2019
Jackson Orem

Kaposi’s sarcoma (KS) is a vascular tumour of endothelial origin that is associated with human herpes virus-8 infection. In sub-Saharan Africa, AIDS-KS remains the most common HIV-associated malignancy, and hence it poses a huge burden to the already constrained health-care systems. KS has four clinical variants, namely, classic, endemic, iatrogenic and epidemic KS. The histopathology in these different KS forms is essentially identical; however, they have different clinical patterns. Expanding knowledge of KS biology increases hope for prevention, disease control, and hence better quality of life among patients. Primary prevention strategy for KS-associated herpes virus and management of disease complication, such as lymphoedema should be the focus of disease prevention and control research.

Article metrics: 586 views
245
341

Related Articles

Rima A Abdul-Khalek, Ghassan Abu-Sitta, Nassim El Achi, Walaa Kayyal, Ahmad Elamine, Aba Noubani, Marilyne Menassa, Fahad Ahmed, Richard Sullivan, Deborah Mukherji
Frederic Ivan Ting, Marvin Jonne Mendoza, Danielle Benedict Sacdalan, Honey Sarita Abarquez, Arnold John Uson
Mariana Peyroteo, Pedro Carvalho Martins, Rita Canotilho, Ana Margarida Correia, Catarina Baía, Alexandre Sousa, Donzília Brito, José Flávio Videira, Lúcio Lara Santos, Abreu de Sousa
Sharada Mailankody, Manikandan Dhanushkodi, Trivadi S Ganesan, Venkatraman Radhakrishnan, Vasanth Christopher, Selvaluxmy Ganesharajah, Tenali Gnana Sagar
Sami Mahjoub Taha, Hsin-Yi Weng, Mohammed El Imam Mohammed, Yassin M Osman, N’sanh N’dri, Sulma I Mohammed, Dafalla Omer Abuidris
Yousef M Al-saraireh, Nafea S Alboaisa, Hamzeh Mohammad Alrawashdeh, Omar Hamdan, Sameeh Al-Sarayreh, Jehad M Al-Shuneigat, Mohammad N Nofal